Carregant...
Proteasomal adaptations underlying carfilzomib-resistance in human bone marrow plasma cells
Donor-specific antibodies (DSAs) have a deleterious effect on allografts and remain a major immunologic barrier in transplantation. Current therapies to eliminate DSAs are ineffective in highly human leukocyte antigen (HLA)-sensitized patients. Proteasome inhibitors have been employed as a strategy...
Guardat en:
| Publicat a: | Am J Transplant |
|---|---|
| Autors principals: | , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6984988/ https://ncbi.nlm.nih.gov/pubmed/31595669 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.15634 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|